These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36038467)

  • 81. Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older.
    van Erning FN; Creemers GJ; De Hingh IH; Loosveld OJ; Goey SH; Lemmens VE
    Ann Oncol; 2013 Nov; 24(11):2839-44. PubMed ID: 23933560
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations.
    Devarakonda S; Sankararaman S; Herzog BH; Gold KA; Waqar SN; Ward JP; Raymond VM; Lanman RB; Chaudhuri AA; Owonikoko TK; Li BT; Poirier JT; Rudin CM; Govindan R; Morgensztern D
    Clin Cancer Res; 2019 Oct; 25(20):6119-6126. PubMed ID: 31300452
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.
    Gallois C; Taieb J; Le Corre D; Le Malicot K; Tabernero J; Mulot C; Seitz JF; Aparicio T; Folprecht G; Lepage C; Mini E; Van Laethem JL; Emile JF; Laurent-Puig P;
    Clin Cancer Res; 2018 Oct; 24(19):4745-4753. PubMed ID: 29921730
    [No Abstract]   [Full Text] [Related]  

  • 84. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
    Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
    Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
    Turner NC; Swift C; Jenkins B; Kilburn L; Coakley M; Beaney M; Fox L; Goddard K; Garcia-Murillas I; Proszek P; Hall P; Harper-Wynne C; Hickish T; Kernaghan S; Macpherson IR; Okines AFC; Palmieri C; Perry S; Randle K; Snowdon C; Stobart H; Wardley AM; Wheatley D; Waters S; Winter MC; Hubank M; Allen SD; Bliss JM;
    Ann Oncol; 2023 Feb; 34(2):200-211. PubMed ID: 36423745
    [TBL] [Abstract][Full Text] [Related]  

  • 86. POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval.
    Bikhchandani M; Amersi F; Hendifar A; Gangi A; Osipov A; Zaghiyan K; Atkins K; Cho M; Aguirre F; Hazelett D; Alvarez R; Zhou L; Hitchins M; Gong J
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239414
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    Otsuka M
    N Engl J Med; 2022 Aug; 387(8):759-760. PubMed ID: 36001721
    [No Abstract]   [Full Text] [Related]  

  • 88. Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    Hindié E
    N Engl J Med; 2022 Aug; 387(8):759. PubMed ID: 36001720
    [No Abstract]   [Full Text] [Related]  

  • 89. When can we be confident of surgical cure with ctDNA?
    Frankell A; Jamal-Hanjani M
    Nat Rev Clin Oncol; 2022 Sep; 19(9):571-572. PubMed ID: 35798966
    [No Abstract]   [Full Text] [Related]  

  • 90. ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials.
    Montagut C; Vidal J
    Ann Oncol; 2019 Sep; 30(9):1410-1413. PubMed ID: 31418008
    [No Abstract]   [Full Text] [Related]  

  • 91. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
    Schraa SJ; van Rooijen KL; van der Kruijssen DEW; Rubio Alarcón C; Phallen J; Sausen M; Simmons J; Coupé VMH; van Grevenstein WMU; Elias S; Verkooijen HM; Laclé MM; Bosch LJW; van den Broek D; Meijer GA; Velculescu VE; Fijneman RJA; Vink GR; Koopman M;
    BMC Cancer; 2020 Aug; 20(1):790. PubMed ID: 32819390
    [TBL] [Abstract][Full Text] [Related]  

  • 92. "Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial".
    Taïeb J; Benhaim L; Laurent Puig P; Le Malicot K; Emile JF; Geillon F; Tougeron D; Manfredi S; Chauvenet M; Taly V; Lepage C; André T
    Dig Liver Dis; 2020 Jul; 52(7):730-733. PubMed ID: 32482534
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer.
    Akagündüz B; Guven DC; Ozer M; Okten IN; Atag E; Unek İT; Tatli AM; Karaoglu A
    J Geriatr Oncol; 2023 Mar; 14(2):101367. PubMed ID: 36038467
    [No Abstract]   [Full Text] [Related]  

  • 94. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
    Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
    [TBL] [Abstract][Full Text] [Related]  

  • 95. New Insights into Adjuvant Therapy for Localized Colon Cancer.
    González NS; Ros Montaña FJ; Illescas DG; Argota IB; Ballabrera FS; Élez Fernández ME
    Hematol Oncol Clin North Am; 2022 Jun; 36(3):507-520. PubMed ID: 35577707
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives.
    Merk C; Martling A; Lindberg J; Benhaim L; Taieb J; Lind P
    Acta Oncol; 2022 Apr; 61(4):523-530. PubMed ID: 35139729
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.